Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart van Hoek

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
JHEP Reports : Innovation in Hepatology|November 30, 2023
Survival benefit from liver transplantation for patients with and without hepatocellular carcinomaBen F J Goudsmit, Ilaria Prosepe, Maarten E Tushuizen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 26, 2021
Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease: The effect of disease development over time on patient outcomeBen F J Goudsmit, Andries E Braat, Maarten E Tushuizen, et al.
Hepatology (Baltimore, Md.)|December 10, 2020
Refitting the Model for End-Stage Liver Disease for the Eurotransplant RegionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Hepatology (Baltimore, Md.)|February 17, 2025
Erratum: Refitting the model for end-stage liver disease for the eurotransplant regionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Journal of Hepatology|July 5, 2012
Preventive versus "on-demand" nutritional support during antiviral treatment for hepatitis C: a randomized controlled trialEllen J Huisman, Bart van Hoek, Hanneke van Soest, et al.
Thrombosis and Haemostasis|April 2, 2003
Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinomaJohan Ph Kuyvenhoven, Bart van Hoek, Eric Blom, et al.
JHEP Reports : Innovation in Hepatology|November 12, 2021
Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failureBen F J Goudsmit, Andries E Braat, Maarten E Tushuizen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 13, 2020
Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant regionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Clinical Transplantation|April 17, 2026
Rhesus Antagonism Is Associated With Non-Anastomotic Biliary Strictures After Orthotopic Liver Transplantation From Brain-Death DonorsLeonard D Niels Broekman, Danny van der Helm, Stefanus G T Janson, et al.
BMC Gastroenterology|December 22, 2010
Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008Edith M M Kuiper, Bettina E Hansen, Herold J Metselaar, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
JHEP Reports : Innovation in Hepatology|November 30, 2023
Survival benefit from liver transplantation for patients with and without hepatocellular carcinomaBen F J Goudsmit, Ilaria Prosepe, Maarten E Tushuizen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 26, 2021
Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease: The effect of disease development over time on patient outcomeBen F J Goudsmit, Andries E Braat, Maarten E Tushuizen, et al.
Hepatology (Baltimore, Md.)|December 10, 2020
Refitting the Model for End-Stage Liver Disease for the Eurotransplant RegionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Hepatology (Baltimore, Md.)|February 17, 2025
Erratum: Refitting the model for end-stage liver disease for the eurotransplant regionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Journal of Hepatology|July 5, 2012
Preventive versus "on-demand" nutritional support during antiviral treatment for hepatitis C: a randomized controlled trialEllen J Huisman, Bart van Hoek, Hanneke van Soest, et al.
Thrombosis and Haemostasis|April 2, 2003
Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinomaJohan Ph Kuyvenhoven, Bart van Hoek, Eric Blom, et al.
JHEP Reports : Innovation in Hepatology|November 12, 2021
Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failureBen F J Goudsmit, Andries E Braat, Maarten E Tushuizen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 13, 2020
Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant regionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Clinical Transplantation|April 17, 2026
Rhesus Antagonism Is Associated With Non-Anastomotic Biliary Strictures After Orthotopic Liver Transplantation From Brain-Death DonorsLeonard D Niels Broekman, Danny van der Helm, Stefanus G T Janson, et al.
BMC Gastroenterology|December 22, 2010
Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008Edith M M Kuiper, Bettina E Hansen, Herold J Metselaar, et al.
Pageof 19